OOIR: Observatory of International Research

Papers

(The H4-Index of Biochimica et Biophysica Acta-Reviews on Cancer is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Tumour cell-induced platelet aggregation in breast cancer: Scope of metal nanoparticles	411
Modeling bladder cancer in the laboratory: Insights from patient-derived organoids	270
Microbial influence on triggering and treatment of host cancer: An intestinal barrier perspective	215
The interaction of SET and protein phosphatase 2A as target for cancer therapy	205
miRNAs and androgen deprivation therapy for prostate cancer	176
Reflections on drug resistance to KRAS inhibitors and gene silencing/editing tools for targeting mutant KRAS in cancer treatment	157
Uveal melanoma modeling in mice and zebrafish	130
VISTA as a context-dependent immune checkpoint: Implications for tumor immunity and autoimmune pathogenesis	111
ESR1 activating mutations: From structure to clinical application	109
TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance	105
Progress and challenges of immunotherapy in triple-negative breast cancer	102
Is tumour-expressed aminopeptidase N (APN/CD13) structurally and functionally unique?	96
Advances in epigenetic modifications and cervical cancer research	92
Nutrition and dietary restrictions in cancer prevention	90
Decoding the role of FOXP3 in esophageal cancer: Underlying mechanisms and therapeutic implications	85
Long non-coding RNAs: Fundamental regulators and emerging targets of cancer stem cells	83
Epigenetic changes associated with Bacillus Calmette-Guerin (BCG) treatment in bladder cancer	79
Insights into the role of connexins and specialized intercellular communication pathways in breast cancer: Mechanisms and applications	79
Biomarkers in high grade serous ovarian cancer	74
Dual perspective on autophagy in glioma: Detangling the dichotomous mechanisms of signaling pathways for therapeutic insights	73
Mitochondrial metabolism in laryngeal cancer: therapeutic mechanisms and prospects	70
CCL20-CCR6 signaling in tumor microenvironment: Functional roles, mechanisms, and immunotherapy targeting	65
Extracellular vesicles in cancer therapy: Roles, potential application, and challenges	65
Transcription factors in glioblastoma – Molecular pathogenesis and clinical implications	64
Contribution of CXCR3-mediated signaling in the metastatic cascade of solid malignancies	60

Prostate cancer: Molecular aspects, consequences, and opportunities of the multifocal nature	57
Advances and prospects of mRNA vaccines in cancer immunotherapy	54
S100A8 and S100A9 in Cancer	53
In what area of biology has a “new” type of cell death been discovered?	52
Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting	51
Targeting lipid metabolism in cancer metastasis	51
Long non-coding RNAs: A view to kill ovarian cancer	48
Small non-coding RNAs and pancreatic ductal adenocarcinoma: Linking diagnosis, pathogenesis, drug resistance, and therapeutic potential	48
Recent insights into RNA m5C methylation modification in hepatocellular carcinoma	48
Prognostic features of the tumour microenvironment in oesophageal adenocarcinoma	48
Multifaceted roles of neutrophils in tumor microenvironment	47
Interleukin-21 as an adjuvant in cancer immunotherapy: Current advances and future directions	47
Targeting Cdc20 for cancer therapy	47
Multiple therapeutic approaches of glioblastoma multiforme: From terminal to therapy	46
Multiple impacts of Naa10p on cancer progression: Molecular functions and clinical prospects	46
Enhancing the anti-tumor response by combining DNA damage repair inhibitors in the treatment of solid tumors	46
The interplay of obesity, microbiome dynamics, and innovative anti-obesity strategies in the context of endometrial cancer progression and therapeutic approaches	45
Nondiploid cancer cells: Stress, tolerance and therapeutic inspirations	45
Editorial Board	45
Vagus innervation in the gastrointestinal tumor: Current understanding and challenges	44
Refinement of safety and efficacy of anti-cancer chemotherapeutics by tailoring their site-specific intracellular bioavailability through transporter modulation	44